Vindesine in Plasma Cell Tumors
Data up to Jan 2025
Total Citations Per Year
Abstract
References (13)
A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival
1975 • 3,051 citations
THE NATURAL HISTORY OF EXTRAMEDULLARY PLASMACYTOMA AND ITS RELATION TO SOLITARY MYELOMA OF BONE AND MYELOMATOSIS
1976 • 670 citations
Plasma cell myeloma: response of melphalan-resistant patients to high-dose intermittent cyclophosphamide.
1972 • 82 citations
Prednisone pulse therapy for refractory myeloma
1983 • 77 citations
Phase I anti-cancer agents Vindesine (desacetyl vinblastine amide sulfate)
1977 • 65 citations
Treatment of multiple myeloma with M-2 protocol and without maintenance therapy
1983 • 31 citations
Antitumor activity of deacetyl vinblastine amide sulfate (vindesine) in rodents and mitotic accumulation studies in culture.
1978 • 31 citations
Vindesine therapy in melphalan-resistant multiple myeloma
1981 • 25 citations
Chemotherapy in the management of extramedullary plasmacytoma
1978 • 24 citations
Vindesine a clinical trial with special reference to neurological side effects
1979 • 15 citations
Hexamethylmelamine and prednisone in the treatment of refractory multiple myeloma.
1982 • 10 citations
Hexamethylmelamine and prednisone in the treatment of refractory multiple myeloma
1982 • 8 citations
Vincristine in the treatment of multiple myeloma.
1980 • 7 citations